The efficacy of a locally injectable prostaglandin EP-2 receptor agonist on fracture healing von Thompson, D.D, Kaplan, I.V, Paralkar, V.M, Buljat, G, Sanders, D, Schwappach, J, Bhandari, M, Vukicevic, S

Volltext

Sustained improvement in vascular endothelial function after short-term dobutamine infusion in patients with severe chronic congestive heart failure von Kaplan, I.V., Patni, R.N., Patel, M.B., Levy, D., Strom, J.A., Shirani, J., LeJemtel, T.H.

Volltext

Iodide sorption to subsurface sediments and illitic minerals von Kaplan, D.I., Serne, R.J., Parker, K.E., Kutnyakov, I.V.

Volltext

Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamide von Abhishek, Abhishek, Yazdani, Ramin, Pearce, Fiona, Regan, Marian, Lim, Ken, Hubbard, Richard, Lanyon, Peter

Volltext

I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo-controlled study von Desmet, M, Braems, H, Reynvoet, M, Plasschaert, S, Van Cauwelaert, J, Pottel, H, Carlier, S, Missant, C, Van de Velde, M

Volltext

Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study von Hu, Y.-D., Xiang, Y.-T., Fang, J.-X., Zu, S., Sha, S., Shi, H., Ungvari, G. S., Correll, C. U., Chiu, H. F. K., Xue, Y., Tian, T.-F., Wu, A.-S., Ma, X., Wang, G.

Volltext

A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients von Pivot, X., Koralewski, P., Hidalgo, J.L., Chan, A., Gonçalves, A., Schwartsmann, G., Assadourian, S., Lotz, J.P.

Volltext

Higher persistency with i.v. bisphosphonates in patients with bone metastasis von Mangiapane, S., Hoer, A., Gothe, H., Barghout, V., Haeussler, B.

Volltext

Phase I trial of 4-demethoxydaunorubicin with single i.v. doses von Kaplan, S., Martini, A., Varini, M., Togni, P., Cavalli, F.

Volltext

Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice von Ben Reguiga, Makrem, Bouquet, Celine, Farinotti, Robert, Bonhomme-Faivre, Laurence

Volltext

Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients von Gabbert, Tatjana I., Hoffmeister, Bodo, Felsenberg, Dieter

Volltext

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer von Tan, E.H., Rolski, J., Grodzki, T., Schneider, C.P., Gatzemeier, U., Zatloukal, P., Aitini, E., Carteni, G., Riska, H., Tsai, Y.H., Abratt, R.

Volltext

GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab von Hadji, P., Kyvernitakis, I., Kann, P. H., Niedhart, C., Hofbauer, L. C., Schwarz, H., Kurth, A. A., Thomasius, F., Schulte, M., Intorcia, M., Psachoulia, E., Schmid, T.

Volltext

A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer von Heinemann, V., Di Gioia, D., Vehling-Kaiser, U., Harich, H.-D., Heinrich, B., Welt, A., Ziske, C., Deutsch, G., Pihusch, R., Kölbl, H., Hegewisch-Becker, S., Michl, M., Stemmler, H.J.

Volltext

Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation von Kahl, C., Sayer, H. G., Hinke, A., Freund, M., Casper, J.

Volltext

OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking s... von Provencher, D.M., Gallagher, C.J., Parulekar, W.R., Ledermann, J.A., Armstrong, D.K., Brundage, M., Gourley, C., Romero, I., Gonzalez-Martin, A., Feeney, M., Bessette, P., Hall, M., Weberpals, J.I., Hall, G., Lau, S.K., Gauthier, P., Fung-Kee-Fung, M., Eisenhauer, E.A., Winch, C., Tu, D., MacKay, H.J.

Volltext

Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function: The randomised Leipzig Immediate PercutaneouS Coronary Intervention Abciximab i.v. versus i.c. in ST-Elevation Myocardial Infarction Trial (LIPSIAbciximab-STEMI) von Eitel, Ingo, Friedenberger, Josef, Fuernau, Georg, Dumjahn, Annett, Desch, Steffen, Schuler, Gerhard, Thiele, Holger

Volltext

Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers von Reshko, Leonid B., Baliga, Sujith, Crandley, Edwin F., Harry Lomas, I.V., Richardson, Martin K., Spencer, Kelly, Bennion, Nathan, Mikdachi, Hana E., Irvin, William, Kersh, Charles R.

Volltext

Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas von Blay, Jean-Yves, Leahy, Michael G, Nguyen, Binh Bui, Patel, Shreyaskumar R, Hohenberger, Peter, Santoro, Armando, Staddon, Arthur P, Penel, Nicolas, Piperno-Neumann, Sophie, Hendifar, Andrew, Lardelli, Pilar, Nieto, Antonio, Alfaro, Vicente, Chawla, Sant P

Volltext

Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial results von BODY, J.J., DIEL, I.J., TRIPATHY, D., BERGSTROM, B.

Volltext